- Home
- BCLI vs MTR Comparison
BCLI vs MTR Comparison
Compare BCLI & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- MTR
- Stock Information
- Founded
- BCLI 2000
- MTR 1979
- Country
- BCLI United States
- MTR United States
- Employees
- BCLI N/A
- MTR N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- MTR Oil & Gas Production
- Sector
- BCLI Health Care
- MTR Energy
- Exchange
- BCLI Nasdaq
- MTR Nasdaq
- Market Cap
- BCLI 9.9M
- MTR 11.7M
- IPO Year
- BCLI N/A
- MTR N/A
- Fundamental
- Price
- BCLI $1.21
- MTR $6.13
- Analyst Decision
- BCLI Strong Buy
- MTR
- Analyst Count
- BCLI 1
- MTR 0
- Target Price
- BCLI $30.00
- MTR N/A
- AVG Volume (30 Days)
- BCLI 35.3K
- MTR 3.7K
- Earning Date
- BCLI 03-31-2025
- MTR 01-01-0001
- Dividend Yield
- BCLI N/A
- MTR 3.00%
- EPS Growth
- BCLI N/A
- MTR N/A
- EPS
- BCLI N/A
- MTR 0.25
- Revenue
- BCLI N/A
- MTR $731,355.00
- Revenue This Year
- BCLI $170.09
- MTR N/A
- Revenue Next Year
- BCLI N/A
- MTR N/A
- P/E Ratio
- BCLI N/A
- MTR $25.12
- Revenue Growth
- BCLI N/A
- MTR N/A
- 52 Week Low
- BCLI $1.05
- MTR $5.60
- 52 Week High
- BCLI $11.25
- MTR $11.99
- Technical
- Relative Strength Index (RSI)
- BCLI 30.68
- MTR 42.62
- Support Level
- BCLI $1.12
- MTR $6.02
- Resistance Level
- BCLI $1.59
- MTR $6.29
- Average True Range (ATR)
- BCLI 0.11
- MTR 0.15
- MACD
- BCLI -0.02
- MTR -0.01
- Stochastic Oscillator
- BCLI 17.31
- MTR 25.09
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.